Goel HL - Search Results

1

Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.

Kang BH, Tavecchio M, Goel HL, Hsieh CC, Garlick DS, Raskett CM, Lian JB, Stein GS, Languino LR, Altieri DC. Kang BH, et al. Among authors: goel hl. Br J Cancer. 2011 Feb 15;104(4):629-34. doi: 10.1038/bjc.2011.9. Epub 2011 Feb 1. Br J Cancer. 2011. PMID: 21285984 Free PMC article.

2

Integrin signaling in cancer.

Goel HL, Languino LR. Goel HL, et al. Cancer Treat Res. 2004;119:15-31. doi: 10.1007/1-4020-7847-1_2. Cancer Treat Res. 2004. PMID: 15164871 Review. No abstract available.

3

Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins.

Goel HL, Fornaro M, Moro L, Teider N, Rhim JS, King M, Languino LR. Goel HL, et al. J Cell Biol. 2004 Aug 2;166(3):407-18. doi: 10.1083/jcb.200403003. J Cell Biol. 2004. PMID: 15289498 Free PMC article.

4

High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression.

Simon EL, Goel HL, Teider N, Wang T, Languino LR, Fitzgerald TJ. Simon EL, et al. Among authors: goel hl. Prostate. 2005 Jun 15;64(1):83-91. doi: 10.1002/pros.20227. Prostate. 2005. PMID: 15651037

5

beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.

Goel HL, Breen M, Zhang J, Das I, Aznavoorian-Cheshire S, Greenberg NM, Elgavish A, Languino LR. Goel HL, et al. Cancer Res. 2005 Aug 1;65(15):6692-700. doi: 10.1158/0008-5472.CAN-04-4315. Cancer Res. 2005. PMID: 16061650

6

Beta1 integrins modulate cell adhesion by regulating insulin-like growth factor-II levels in the microenvironment.

Goel HL, Moro L, King M, Teider N, Centrella M, McCarthy TL, Holgado-Madruga M, Wong AJ, Marra E, Languino LR. Goel HL, et al. Cancer Res. 2006 Jan 1;66(1):331-42. doi: 10.1158/0008-5472.CAN-05-2588. Cancer Res. 2006. PMID: 16397247

7

Regulation of survivin expression by IGF-1/mTOR signaling.

Vaira V, Lee CW, Goel HL, Bosari S, Languino LR, Altieri DC. Vaira V, et al. Among authors: goel hl. Oncogene. 2007 Apr 26;26(19):2678-84. doi: 10.1038/sj.onc.1210094. Epub 2006 Oct 30. Oncogene. 2007. PMID: 17072337

8

The integrin-growth factor receptor duet.

Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR. Alam N, et al. Among authors: goel hl. J Cell Physiol. 2007 Dec;213(3):649-53. doi: 10.1002/jcp.21278. J Cell Physiol. 2007. PMID: 17886260 Review.

9

Integrins in prostate cancer progression.

Goel HL, Li J, Kogan S, Languino LR. Goel HL, et al. Endocr Relat Cancer. 2008 Sep;15(3):657-64. doi: 10.1677/ERC-08-0019. Epub 2008 Jun 4. Endocr Relat Cancer. 2008. PMID: 18524948 Free PMC article. Review.

10

Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention.

Fitzgerald TJ, Wang T, Goel HL, Huang J, Stein G, Lian J, Davis RJ, Doxsey S, Balaji KC, Aronowitz J, Languino LR. Fitzgerald TJ, et al. Among authors: goel hl. Expert Rev Anticancer Ther. 2008 Jun;8(6):967-74. doi: 10.1586/14737140.8.6.967. Expert Rev Anticancer Ther. 2008. PMID: 18533806 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters